Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy Asati
Current Molecular Targets of Heterocyclic Compounds for Cancer TherapyAuthor(s): Vivek Asati, Ankur Vaidya\nFormat: Paperback\nPublisher: Elsevier Science & Technology, United Kingdom\nImprint: Academic Press Inc\nISBN-13: 9780323961219, 978-0323961219\nSynopsis\nCurrent Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1. The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. Thi.
Compare prices (3 shops)
| shop | Price | Action |
|---|---|---|
|
106,00 GBP | Go to shop |
|
|
107,19 GBP | Go to shop |
|
|
109,39 GBP | Go to shop |
Similar products
-
Cancer Signaling: From Molecular Biology to Targeted Therapy
From 52,85 EUR -
-
-
-
-
